ANXA6 and cancer: Chemotherapeutic agents have been reported to stimulate the secretion of EVs containing various biologically active substances, such as ABCB1, annexin A6, miR-9-5p, miR-203a-3p, and miR-195-5p, promoting chemoresistance and cancer invasiveness [6,8,37].